Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults ...

'It finished three days before Christmas. I was sleeping on Christmas day,' she said. Two weeks later and she has finally ...

A cancer dietician has shared a list of items she says are safe to eat and drink without increasing the risk of developing ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

Healthcare experts have listed funding, corporate investments, and other factors as priorities to drive economic growth in Nigeria's healthcare sector ...

The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...

New understanding about cancer and its treatment already informs cancer care and offers options that weren't possible even a few years ago. Nuffield Trust. Cancer survival rates. Wangchinda P, ...